National Centre for Pharmacoeconomics

Recent papers from National Centre for Pharmacoeconomics

1. RENOVATE Healthcare Ireland & Ukraine: Economic protocol for comparative cost-effectiveness of available health interventions for depression, according to symptom severityHRB Open Research · 2026
2. Adjusting Survival Curves to Incorporate External Evidence: A Simplified Approach without Patient-Level DataMedical Decision Making · 2026
3. Collaborating for Affordable Patient Access to Medicines: Review of the First Decade of the Beneluxa Initiative in Pharmaceutical PolicyApplied Health Economics and Health Policy · 2026
4. Examining the emotional impact and financial strain on caregivers of those with Duchenne muscular dystrophy in Saudi Arabia: findings from a questionnaire-based cross-sectional studyFrontiers in Psychology · 2026
5. An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohortsAge and Ageing · 2026
6. Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspectiveExpert Review of Pharmacoeconomics & Outcomes Research · 2026
7. Pneumonia due to respiratory syncytial virus does not cause long-lasting disorders in respiratory gas transport after clinical resolution in adults. Comparison vs. SARS-CoV-2 pneumoniaMonaldi Archives for Chest Disease · 2026
8. Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia BJournal of Thrombosis and Haemostasis · 2026
9. How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EUBritish Journal of Clinical Pharmacology · 2026
10. Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and SpainPharmacoEconomics · 2026
11. Responses to active stand test predict 12-year incident cardiovascular disease and mortalityCommunications Medicine · 2025
12. Multimorbidity patterns in Irish adults ageing with and without an intellectual disability using network analysis and association rules: A comparative analysis using data from the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS-TILDA)Journal of Intellectual Disabilities · 2025
13. Planetary health and environmentally sustainable healthcare: perceptions of primary care practitioners in Ireland – a qualitative studyBMJ Open Quality · 2025
14. Prospective associations between diabetes and depressive symptoms across European regions: a secondary analysis of ELSA, TILDA, and SHARE datasetsEuropean Journal of Public Health · 2025
15. A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in IrelandValue in Health · 2025
16. Particularities of Chronic Urticaria in Latin American Countries: Epidemiology, Pathogenesis and TreatmentCurrent Treatment Options in Allergy · 2025
17. Primary healthcare’s carbon footprint and sustainable strategies to mitigate its contribution: a scoping reviewBMC Health Services Research · 2024
18. Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric CancerPharmacoEconomics · 2024
19. mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infectionsMultidisciplinary Respiratory Medicine · 2024
20. Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory DiseasesRevista Alergia México · 2024